Anne Nafziger
Internal Medicine · Albany, NYNPI 1215010624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Braeburn Inc. at 40.4% of the total. Reporting peaked in 2024 at $367 and has fallen 65.7% since, to $126 in 2025.
Across 6 payments — averaging $103.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Braeburn Inc.$252
- Gilead$123
- Axsome Therapeutics, Inc.$122
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$109
- Astrazeneca UK Limited$17
Across 67 payments — averaging $12,719 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$427K
- Modernatx, Inc.$329K
- AstraZeneca$66K
- AbbVie$29K
What the payments were for
- Food & beverage$623100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Braeburn Inc. | 2 | $252 |
| Gilead | 1 | $123 |
| Axsome Therapeutics, Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $109 |
| Astrazeneca UK Limited | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$623 in reported general payments places this provider in the 65th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Albany
- Scott BeegleAlbany$1.9M
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
- James UnderbergNew York$953K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.